The Cure have set new tour records, despite fighting to lower the price of tickets.
The Robert Smith-fronted band's recent tour of North America, which ended earlier in July, is officially the highest-grossing of their 45-year-long career. Prior to this tour, the most tickets they had sold took place during their North American Wish tour in 1992, which sold 402,000 tickets.
The legendary English band recently finished a 35-date tour of the continent after previously touring Europe in 2022.
As reported by Billboard, the tour grossed $37.5 million and sold over 547,000 tickets. The final date took place in Miami, Florida, earlier this month.
The report also says that the most attended and highest-earning shows on the North American leg was the band's three-night residency at the Hollywood Bowl in Los Angeles. The three shows brought in $4.9 million and sold over 50,800 tickets.
The band were able to set the record even while fighting to keep ticket prices low. Earlier this year, Smith spoke out against excessive ticket fees and claimed that he was "sickened" by the added service fees, facility charges and processing fees added onto the price of the band's tour tickets.
He spoke directly to Ticketmaster about the hiked-up prices, and later told his followers on Twitter, "After further conversation, Ticketmaster have agreed with us that many of the fees being charged are unduly high, and us a gesture of goodwill have offered a $10 per ticket refund to all verified fan accounts for lowest ticket price ('LTP') transactions…"
(Photo: Bill Ebbesen)
For comments and feedback contact: editorial@rttnews.com
Entertainment News
December 26, 2025 08:42 ET Third quarter economic growth data from some major economies including the U.S. were the main news in this holiday shortened week. GDP growth and industrial production data from the U.S. helped to boost morale, while the consumer confidence survey results were less upbeat. In Europe, the quarterly economic growth data from the U.K. drew attention, while the minutes of the Australian central bank’s latest policy session was in focus in Asia.